Aurora Financial JournalBioArctic AB (BIOAB.ST)
Nasdaq Stockholm · Financial statements, TTM figures and earnings dates
In fiscal year 2024 (ended December 31, 2024), BioArctic AB reported revenue of SEK 257.4M and net income of −SEK 177.1M. Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).
Open interactive financials →Key financials
| SEK | FY2024 2024-12-31 | FY2023 2023-12-31 | FY2022 2022-12-31 | FY2021 2021-12-31 | FY2020 2020-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | SEK 257.4M | SEK 616.0M | SEK 228.3M | SEK 23.1M | SEK 62.3M |
| Gross profit | SEK 230.4M | SEK 601.0M | – | – | – |
| Operating income | −SEK 228.5M | SEK 252.6M | – | – | – |
| Net income | −SEK 177.1M | SEK 229.2M | −SEK 11.2M | −SEK 119.8M | −SEK 68.5M |
| Diluted EPS | – | – | −SEK 0.13 | −SEK 136000.00 | −SEK 78000.00 |
| Cash flow | |||||
| Capital expenditure | SEK 26.6M | SEK 7.4M | SEK 12.7M | SEK 4.4M | SEK 12.5M |
| Balance sheet | |||||
| Cash and equivalents | SEK 512.9M | SEK 611.6M | SEK 805.4M | SEK 848.4M | SEK 999.9M |
| Total assets | SEK 1.11B | SEK 1.19B | SEK 858.3M | SEK 897.7M | SEK 1.05B |
| Total liabilities | SEK 216.7M | SEK 139.5M | SEK 72.1M | SEK 109.1M | SEK 143.0M |
| Shareholders' equity | SEK 894.9M | SEK 1.05B | SEK 786.2M | SEK 788.7M | SEK 907.3M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full BIOAB.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open BIOAB.ST financials →